Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. (2015)

First Author: Oza AM
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(15)00086-8

PubMed Identifier: 26115797

Publication URI: http://europepmc.org/abstract/MED/26115797

Type: Journal Article/Review

Volume: 16

Parent Publication: The Lancet. Oncology

Issue: 8

ISSN: 1470-2045